Scientists at Harvard's Wyss Institute for Biologically Inspired Engineering have unveiled their newest tool for drug testing, dubbed bone marrow-on-a-chip, the first device of its kind that mimics the structure, functions and cellular make-up of ... BioScreening, 2 weeks ago
By a News Reporter-Staff News Editor at Biotech Week -- CAMBRIDGE, MA - MIT chemical engineers have devised a new implantable tissue scaffold coated with bone growth factors that are released slowly over a few weeks. When applied to bone injuries or ...HispanicBusiness.com, 1 month ago MIT - Engineering new bone growth HispanicBusiness.com, 1 month ago Chemical engineers devise new implantable tissue scaffold coated with bone growth factors News-Medical.Net, 1 month ago Engineering bone growth: Coated tissue scaffolds help body grow new bone to repair injuries or congenital defects Science Daily, 1 month ago
I n an advance against cancer metastasis, scientists at the Harvard-affiliated Dana-Farber Cancer Institute have shown that a specially developed compound can impede multiple myeloma in mice from spreading to the bones. The findings, published in ...Harvard University Gazette, 6 days ago Novel compound prevents metastasis of multiple myeloma in mouse studies EurekAlert!, 6 days ago
HARVARD APPARATUS REGENERATIVE TECH : Is Regenerative Medicine a New Growth Market for Biotech Investors?
Medical technology is intimately linked to regenerative medicine. You could say these industries have a thunder-and-lightning relationship--you can't have one without the other. Mark Landy , director of research for medical technology and ...4 Traders, 1 month ago Is Regenerative Medicine a New Growth Market for Biotech Investors? HispanicBusiness.com, 1 month ago Biotech Stock Directory Update InvestorIdeas.com, 1 month ago New Growth Ideas for Biotech Stock Investors Market Oracle, 1 month ago
BY ROBERT H. CARLSON NEW YORK -- After a data-filled debate between two hematology experts on whether newly diagnosed multiple myeloma patients should be treated with transplantation right away or later on, the audience voted. And the ...Oncology Times, 4 days ago
Dr. James Schaller of Naples Florida shares a scientific breakthrough which could change the lives of millions who suffer from depression and arthritis. Current synthetic antidepressants share problems that include weight gain, sexual dysfunction, ...PRWeb, 1 week ago
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1.....predicting degree of reservoir reduction needed for cure
Download the PDF here September 16, 2014 PNAS Proceedings of the National Academy of Sciences of the United States of America Alison L. Hilla,b,1,2, Daniel I. S. Rosenblooma,c,1, Feng Fud, Martin A. Nowaka, and Robert F. Silicianoe,f ...National AIDS Treatment Advocacy Project, 1 week ago
SEATTLE Sept. 17, 2014 Researchers at Fred Hutchinson Cancer Research Center received a five-year, $12.5 million award from the National Institute of General Medical Sciences that designates the Seattle campus as a MIDAS Center of Excellence.Fred Hutchinson Cancer Research Center, 2 weeks ago
When Steve Brozak performs diligence on biotech stocks, he's always looking for an angle. Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system, ...Equities.com, 2 weeks ago Whats behind FDA's fast paced molecular entity approvals? CommodityOnline, 3 weeks ago Steve Brozak: Big-Picture Biotech Stocks Rule the Future Jutia Group, 3 weeks ago
Genome Engineering & CART Cells: At the forefront of immuno-oncology Regulatory News: Cellectis (Paris:ALCLS) (Alternext: ALCLS.PA), a leader in the development of adoptive immunotherapies based on engineered allogeneic ...4 Traders, 2 weeks ago Event report: Cellectis R&D/ Analyst Day Street Sweeper, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!